Apolipoprotein B100 is a suppressor of Staphylococcus aureus-induced innate immune responses in humans and mice

Lipoteichoic Acid-Induced Lung Inflammation Depends on TLR2 and the Concerted Action of TLR4 and the Platelet-Activating Factor Receptor

(2014) S. Knapp et al.   JOURNAL OF IMMUNOLOGY

Pharmacological strategies for lowering LDL cholesterol: statins and beyond

(2011) Ariel Brautbar et al.   Nature Reviews Cardiology

Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic

(2010) M. Z. David et al.   CLINICAL MICROBIOLOGY REVIEWS

Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe

(2010) Gilbert R Thompson et al.   CURRENT OPINION IN LIPIDOLOGY

Internalization and Coreceptor Expression Are Critical for TLR2-Mediated Recognition of Lipoteichoic Acid in Human Peripheral Blood

(2010) S. Bunk et al.   JOURNAL OF IMMUNOLOGY

The role of HDL in innate immunity

(2010) Kenneth R. Feingold et al.   JOURNAL OF LIPID RESEARCH

Recognition of Lipopeptide Patterns by Toll-like Receptor 2-Toll-like Receptor 6 Heterodimer

(2009) Jin Young Kang et al.   IMMUNITY

Apolipoprotein B Is an Innate Barrier against Invasive Staphylococcus aureus Infection

(2008) M. Michal Peterson et al.   Cell Host & Microbe

Apolipoprotein A-I diminishes acute lung injury and sepsis in mice induced by lipoteichoic acid

(2008) Yan-ling Jiao et al.   CYTOKINE

Polypropylene glycol is a selective binding inhibitor for LTA and other structurally related TLR2 agonists

(2008) Christian Draing et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Kupffer cell products and interleukin 1? directly promote VLDL secretion and apoB mRNA up-regulation in rodent hepatocytes

(2008) Nerea Bartolomé et al.   Innate Immunity